Matt Marsh
Analyst · Andrew Johnston from CLSA. Please go ahead
Thanks Louis, good morning everybody. On page 16 Louis has hit some of these already for the group earnings we're favorably impacted by sales volume across the all the business units in our segments higher average sales prices in the U.S and Europe segments input cost remain elevated for both the quarter in the nine months has been pretty consistent with what we’ve talked about throughout most of the year. As a result of production cost are higher for the nine months across the network as Louis said the plans are really starting to run well and are starting to offset a lot of that. Organization spend is higher compared to a year ago. But still as a percentage sales its trending in an area that we wanted to trend them it's largely related to organizational adds that we're making in order to have the capabilities in place for the expected growth that we see some discretionary spend as well as in foreign currency impacts. The net operating cash flows for the quarter were 104 million compared to 254 for the nine months a year ago and we'll go to that a bit really two primary drivers there the payment and the fund and some working capital of the two primary items and then as Louis is already highlighted. The continued capital expenditures on the capacity projects remain on track and are going to be little higher this year as we've eluted to in November. But for the over the course of 24 month period will be in line with that $600 million facing over the three year period that we've talked about. On page 17 these are the reported results, I'll take you over the next couple of pages through that for the quarter and then for the nine months. So net sales up 10 favorably impacted by sales volume and price in the U.S segment; gross profit margins are increase by 40 basis points, a combination of average sales price in the U.S. partially offset by the higher input cost price and those input cost prices are starting to partially be offset by the production efficiency and the plant performance in the network. And as I mentioned SG&A expenses are up year-over-year about 4% in the quarter, a combination of labor expense and the discretionary expense as well as foreign currency, items between EBIT so you get a reported EBIT of 33% and we'll go to the adjustments in a moment. The low EBIT and net income obviously interest expense has increased, it'll continue to increase as we're now in the debt position and we weren’t in a debt position a year ago, so that's got an adverse impact year-over-year as well as in other income some interest rate swaps as interest rates remain off of what I think are most people's expectations. Income tax expense are higher largely the result of two items one is just the geographic mix of earnings, but also a year ago, we had a tax adjustment related to the favorable resolution of an amended tax audit and a final receipt from that adjustment from the [indiscernible] I'll cover in a bit more detail later. If you go to Page 18, so now going from operating profit on reported basis down to the adjusted [audio-gap] were due to a 7% change in the Australian dollar and U.S. dollar exchange rate compared to a 4% change in the stock rates a year ago. We're viewing weather tightness improved year-over-year we had a favorable claim that settled within the third quarter and as a result of those of that combined with just higher rate of claim resolution overall that provision continues to increase and adjusted net operating profit of 48.6 for the three months up 11% and you can see most of the items we've already talked about for the most part. On Page 19 is the nine months, so very similar for the nine months net sales increased 11% similarly driven by sales volumes and average net selling prices in local currencies across all of our segments for the nine months. Gross profit margins are up slightly versus a year ago when you compare the nine months of '15 to the nine months of '14. Similar dynamics, higher average selling price partially offset by input prices remain high and plant performance starting to offset some of that, but a combination of those items is expanding gross margins for the nine months. SG&A expenses is a similar dynamic for the nine months as we've talked about earlier for the three months and earlier in the year. And non-operating items I think very similarly interest expense is up because of the debt facilities as well as foreign exchange and interest rate swaps unfavorably impacting the nine month period. You go to Page 20, the 263.6 net operating profit on a reported basis adjusts to 164.1 for the nine months ending December that's up 8% that's the difference there is really driven by asbestos adjustments were up 11% because of exchange as compared to about 14% change in stock rates a year ago. Moving on, weather tightness continues to move in a favorable way and adjusted net operating profit up 8 a combination of operating EBIT across the segments up about 14 for the group 14% partially offset by interest expense the other expense items which we talked about the interest rate swaps and foreign currency as well as income tax expenses are up in line with earnings. On Page 21 gross profits of 34.8% for the third quarter. You can see in line with the EBIT margin rates that we showed earlier for the U.S. and Europe segment [indiscernible] the gross margin rates have really stabilized over the last four quarters or five quarters and have trended up a bit. Prices has improved as we continue to execute on both the pricing and efficiencies as well as the market increases that we've done as well as getting the plant performance on a positive trend line has helped to offset some of the input cost as market prices for pulp, gas and silica and some of the other raw materials remain at elevated level. On Slide 22, is a similar chart to what we showed over the last several quarters on U.S. input cost. You can see that overall the input cost remain fairly elevated but they have started to at least paper and some of them for example electricity and gas have started to come down. They are up significantly year-over-year pulp in particular has remained much higher throughout the year than most forecast externally had nine months ago expected. We're performing I'd say in most of these categories our sourcing strategies are resulting in us having less inflationary impact in the marketplaces but nonetheless the marketplaces overall are up year-over-year. On page 23 so three year trends for the segments the U.S Europe fiber cement segment at nine months EBITA up to a 6.3 in comparison to 179 to 8 for the nine months of fiscal 14. For the quarter in the nine months the EBIT in the U.S up about 20% and 15% respectively compared to the prior periods and similar dynamics that we've already talked about. Volume and price partially offset by input cost and we're continuing in the U.S to invest in the organization for growth. Asia Pacific for the quarter and nine month EBIT is up 10% and 8% respectively compared to the same period a year ago and local currency the amounts are 20% and 14% for the quarter and nine months respectively. We go to page 24, research and development continues on a very similar term line broadly in line with our historical trends. Again we kind of see quarter to quarter fluctuations but that’s really just reflective of timing of various projects coming on and off really no change in research and development. For general cooperate cost for the quarter and for the nine months those are up year over year 33.3 for the nine months compared to 30.9 for the nine months of fiscal 14 a combination of discretionary spend which is both labor cost as well as discretionary spend in product and marketing and inner role cooperate activities some foreign exchange losses those were partially offset by decrease in stock compensation as a result of the changes in our share price. On page the most significant foreign exchange adjustments for us obviously the Australian dollar very similar chart exactly in chart that we showed now for quite some time. The strengthening of the dollar and the weakening in the Australian dollar had an unfavorable impact on the translation Asia Pacific segment results in the U.S dollar at a favorable impact on our cooperate cost that are based in Australian and incurred in the Australian dollar and then have a favorable impact on the translation of asbestos balanced. On slide 26 the ETR for the year is estimated to be 23.6 for the adjusted effective tax rate that’s largely in line with last quarter and reflected to what we think of these for the year. Adjusted income tax expense and adjusted ETR has increased year over year largely due to the geographic mix of earnings and earnings in jurisdiction with higher tax rates. We've address earlier the main difference in the adjusted income tax expense line item is primarily due to the non-recurring receive from the ATO relating to the finalization of the disputed amended assessment and that was in the third quarter of fiscal '14. And then just a couple other items on income tax are paid in payable and Ireland and U.S and Canada, New Zealand, Philippines are not paid or payable in Europe or Australia largely due to the Australian tax losses. And the deduction that result from the contributions that we make annually to the asbestos trust. On slide 27 we had cut cash flow from operations for the nine months of 104 million compared to 254.7 million for the nine months of fiscal '14. Adjusted EBIT increased almost 28 million compared to the prior corresponding periods, the cash flow from operating activity this year includes $113 million contribution AICF. Working capital is increased year over year and has driven a use of cash primarily driven by inventory really on three areas raw material as we've just try to rebalance the raw material across the network. Obviously the commissioning of Fontana has required inventory and then there is just a traditional seasonality that is contributing to higher inventory as well. We spend $241 million for the first nine months on capital expenditures largely to the plant capacity expansion and the land I'll provide some additional detail amount in the following page and our gross debt position of about 390 million at the end of December. On page 28 you do a breakdown of the CapEx spend for the first nine months of 241 breakdown in broadly in the three categories. So the two parcels of land that we purchased for about 65 million one of those was a purchase of Tacoma site that’s adjacent to our existing Tacoma facility we made that purchased in the summer and we anticipate that will be the site for some Greenfield capacities down the road. We in December closed on land transaction of our [Rotel] facility and we had previously leased that site and that came on market and we were able to purchase that land for a good economic outcome for us. So those are two pieces of land, the construction of the Brownfield capacities are largely complete or sort of nearing completion in plant city in Cleburne, Texas and in Carole Park and then the maintenance and other CapEx is broadly in line with historical levels for us. On slide 29, is the financial management framework that we've used now for a couple of quarters and you should expect us to continue to use no real change in the overall framework, we're continuing to start with the strong financial management which starts with strong margins and operating cash flows coupled with insuring that we're very transparent and have good governance mechanisms in place and then overall philosophy in terms of how we view the balance sheet? How we view our financial management policies as - investment grade like company. No real substantial change in capital allocation, our first priority is continues to be and will continue to be investing in research and development and capacity expansion to support the market penetration and the market opportunities for organic growth. We remain committed to maintaining ordinary dividend within the defined payout ratio and then maintaining flexibility on our balance sheet for a variety of items including either accretive and strategic organic opportunities, market cycle given them we're in a cyclical industry as well as further shareholder returns as those are appropriate. From a liquidity and funding standpoint at the end of December, we had $590 million of bank facilities was about 44% liquidity, at that time about 2.7 average weighted debt maturity on those profile and given our desired goal to have a long term debt position within our stated range of one to two times EBITDA minus - payment, we completed the sale of $325 million of 8 year senior unsecured notes price debt 5.875% just two weeks ago and that was as much about getting the maturity of the balance sheet in line with a long term debt strategy and ensuring that we weren't fully relying on short term bank facilities as it was anything else. Our leverage still remains very conservative within our stated range. Page 30, provides a little bit more information on liquidity, as of December the amounts in the bars and the tables did not reflect the bond but our balance sheet remains strong as $52 million of cash at the end of December, almost $600 million of bank lines adequate levels of liquidity, net debt on the books of about $328 million compared to net cash a year ago of 158. I have touched on the bond already, we remain committed to the net debt target of one to two times our EBITDA excluding asbestos and we remain in compliance with all our covenants. On slide 31 is an update on New Zealand weather tightness. You can see the blue line is continue to trend down for the nine months New Zealand weather tightness is moved from an expense of about 700,000 to a benefit of about 4 million, that’s really driven by a combination of few claims, favorable claim settlements, higher rate of claim resolution and a continued reduction in the number of overall claims. So at the end of December, that provision was approximately 2.4 million and that compared to about 12.7 million in the prior corresponding period. On page 32, an update on asbestos for the quarter and the nine months claims received by the trust during the quarter we're up about 11% above the actuarial estimates for the quarter and nine months they're up about 10% and 7% respectively higher than a prior corresponding period. The higher reported mesothelioma claims experience that we saw in fiscal '14 and in the first half of fiscal '15 that trend has continued for the nine months. The average claim settlement for the nine months is down about 5% versus prior corresponding period and down 15% versus the actuarial estimates. The average size of the claim settlement sizes are generally lower across all the disease types although I'd just caution that again were nine months into a full year and I think it's really best to look at some of the claims, trends with the full year of data. Actual dollars paid in compensation was about 1% above the nine months actuarial estimate and on pro-rata basis and you can see AICF on the right had cash and investments at the December of $48.8 million. On slide 33, just to summarize group net sales have increased 10% and 11% for the quarter and the nine months when compared to the same period a year ago. Adjusted group net operating profit is up 11% for the quarter and 8% for the nine months compared to the same period a year ago. Volumes and net sales for the nine months in our U.S. and Europe segment as well as our Asia-Pacific segment have increased. As Louis said at the beginning the U.S. residential market has remained slow or soft and that anticipate an accelerated growth that had not come to the first nine months. We're continuing obviously to invest in both our organizational capability and capacity as we're continuing to execute on our market penetration objectives and anticipation that the market will continue in the medium term and the long-term to recover and we continue to expect our EBIT margins to stay within our range our stated range of 20% to 25% for the U.S. and Europe segment. So with that, I'll we'll close and we'll open it up to any questions.